Several previously healthy children were admitted for suspected hepatitis and tested positive for human adenovirus. Was there a connection?
A common cause of respiratory and gastrointestinal infections in humans, human adenovirus (HAdV), it is an uncommon cause of end-organ disease in children. It surprised clinicians when, from October 2021 to February 2022, in a single center for significant hepatitis, several previously healthy children were admitted and, ultimately, tested positive for human adenovirus (HAdV).
HAdVs are nonenveloped viruses containing double-stranded deoxyribonucleic acid. While it can be serious and even fatal in immunocompromised individuals, HAdV disease is typically mild. Of note, HAdVs establish persistent infections due to reactivation that can contribute to risk in the immunocompromised, said a study published in Science Direct.
In another study presented in a poster at the IDWeek Conference in Washington, DC, on October 19-23, 2022, Markus A. Buchfellner, MD, the presenting author, pediatric infectious diseases fellow at Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, and his coauthors note that the intention of the investigation was to describe these children’s characteristics.
In the study, “Case Series of Children with Hepatitis and Adenovirus Infection, Alabama, October 2021—February 2022,” the investigators propose that HAdV is a potentially underrecognized cause of hepatitis, and that other clinicians may prefer whole blood specimens over plasma for HAdV RT-PCR testing. In all the child patients, HAdV type 41 was identified typing results available. Buchfellner and his team added that determining HAdV patterns of circulation and informing future diagnostic testing by improved type-based surveillance may help.
The investigators only included children admitted to Children’s of Alabama (COA) with hepatitis who tested positive for HAdV by whole blood RT-PCR from October 2021 to February 2022. From medical records, the team collected demographic, clinical, laboratory, and treatment data. The children’s residual blood specimens were sent by Buchfellner and his team for adenovirus typing.
A total of 9 pediatric patients with hepatitis and HAdV infection were identified, of whom 78% were female with a median age of 3.0 years. The interquartile range (IQR) was 1.7-3.0 years. Before the children were admitted, 6 reported diarrhea, and 3 had respiratory symptoms.
The investigators noted on the poster: “At presentation, 8 had scleral icterus, 6 had jaundice, 7 had hepatomegaly, and 1 was encephalopathic. All patients had elevated transaminases (AST range: 447-4000 U/L, ALT range: 784-4695 U/L); initial total bilirubin varied [range 0.23-13.5 mg/dL]). All had confirmed HAdV by RT-PCR on whole blood (initial qPCR range: 991-70,680 copies/mL).”
Markedly, 2 children who had been transferred to another facility and whose plasma had been tested instead of whole blood were negative for HAdV by RT-PCR.
Of the children tested, 6 children ultimately underwent liver biopsy showing varying degrees of hepatitis with no adenovirus detected on immunohistochemistry stains. HAdV type 41 was confirmed in 5 patients. Of the tested children, three patients presented or progressed to acute liver failure; 2 children were treated with cidofovir, and, eventually, 2 underwent successful liver transplantation.
Of mention, no known epidemiologic links between patients were identified, and all the children were from geographically distinct parts of Alabama.
The total number of children whose blood was tested was not noted in the description of the poster.
Co-Authors of this study are the following: L. Amanda Ingram, MPH, Alabama Department of Public Health, Montgomery, Alabama; Henry Shiau, MD, Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Alabama at Birmingham, Children's of Alabama, Birmingham, Alabama; Luz Helena Gutierrez Sanchez, MD, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Alabama at Birmingham, Children's of Alabama, Birmingham, Alabama; Stephanie Saaybi, MD, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Alabama at Birmingham, Birmingham, Alabama; William Britt, MD, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama; Veronica Sanchez, PhD, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama; Jennifer L. Potter, MPH, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama; David Kelly, MD, Division of Pathology, University of Alabama at Birmingham, Children's of Alabama
Birmingham, Alabama; Xiaoyan Lu, MS, epidemiologist, Centers for Disease Control and Prevention, Atlanta, Georgia; Stephanie Ayers-Millsap, MPH, Jefferson County Department of Health, Birmingham, Alabama; Wesley G. Willeford, MD, Jefferson County Department of Health, Birmingham, Alabama; Negar Rassaei, MD, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia; Hannah Bullock, PhD, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia; Sarah Reagen-Steiner, MD, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia; Ali Martin, Alabama Department of Public Health, Montgomery, Alabama; Daryl M. Lamson, Wadsworth Center, New York State Department of Health, Albany, New York; Umesh D. Parashar, MD, MBBS, medical officer, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia; Aron J. Hall, DVM,Respiratory Viruses branch chief (acting), Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia; Adam MacNeil, PhD, epidemiologist, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia; Jacqueline E. Tate, PhD, lead, epidemiology team, Viral Gastroenteritis branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia; Hannah L. Kirking, MD, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.